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Reliability of self-reported history in predicting immunity
against measles, rubella, mumps, and varicella among health
care workers
Çiğdem ATAMAN HATİPOĞLU1, Ferah ERGİN1, Günay TUNCER ERTEM1, Cemal BULUT1,
Rukiye BERKEM2, Ali Pekcan DEMİRÖZ1

Aim: To determine the immunity of health care workers (HCWs) against measles, rubella, mumps, and varicella
infections, and to evaluate the reliability of self-reported history of the disease in predicting immunity.
Materials and methods: A self-reported questionnaire was used to obtain the history of the diseases and ELISA to screen
specific IgG antibodies. The history of the diseases was compared with serological testing results.
Results: Eighty-one HCWs were included in the study. Immunity against measles was 97.5%, rubella 100%, mumps
72.8%, and varicella 96.3%. Positive predictive values of positive histories of the diseases were 100% for measles and
rubella, 96.5% for varicella, and 77.4% for mumps. The negative predictive values of the negative/unknown histories
were 3.9%, 0%, 3.8%, and 30.0% for measles, rubella, varicella, and mumps, respectively.
Conclusion: A positive history of the disease is reliable for predicting the immunity against measles, rubella, and varicella,
and vaccination is not required for the HCWs with a positive history. In contrast, a negative/unknown history had no
benefit in predicting susceptibility; thus, we consider that these HCWs must be vaccinated according to the serological
testing results. For mumps, a decision for vaccination of HCWs can be made by combining the self-reported history and
serological testing results.
Key words: Measles, rubella, mumps, varicella, seroprevalence, health care worker

Sağlık çalışanlarının kızamık, kızamıkçık, kabakulak ve suçiçeği geçirme öykülerinin
immüniteyi tahmin etmedeki güvenilirliği
Amaç: Bu çalışmada sağlık çalışanlarının kızamık, kızamıkçık, kabakulak ve suçiçeğine karşı immünitelerinin
belirlenmesi ve hastalığı geçirme öyküsünün immüniteyi tahmin etmedeki güvenilirliğinin değerlendirilmesi
amaçlanmıştır.
Yöntem ve gereç: Sağlık çalışanlarının hastalığı geçirme öyküleri anket formlarına kaydedilmiştir, spesifik IgG antikorları
ELISA yöntemi ile tespit edilmiştir. Hastalığı geçirme öyküleri serolojik test sonuçları ile karşılaştırılmıştır.
Bulgular: Seksen-bir sağlık çalışanı çalışmaya dahil edilmiştir. Çalışma grubunun % 97,5’inin kızamığa, % 100’ünün
kızamıkçığa, % 72,8’inin kabakulağa ve % 96,3’ünün suçiçeğine karşı bağışık olduğu saptanmıştır. Hastalığı geçirme
öyküsünün immüniteyi tahmin ettirme oranı kızamık ve kızamıkçık için % 100, suçiçeği için % 96,5, kabakulak için %
77,4 olarak bulunmuştur. Hastalığı geçirmeme veya geçirip geçirmediğini bilmeme öyküsünün immün olmamayı tahmin
ettirme oranı kızamık, kızamıkçık, suçiçeği ve kabakulak için sırasıyla % 3,9, % 0, % 3,8 ve % 30,0 olarak saptanmıştır.
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Sonuç: Hastalığı geçirme hikayesinin kızamık, kızamıkçık ve suçiçeğine karşı immüniteyi tahmin ettirmede güvenilir
olduğu ve hastalığı geçirme hikayesi olan sağlık personelini aşılamaya gerek olmadığı sonucuna varılmıştır. Aksine,
hastalığı geçirmeme veya geçirip geçirmediğini bilmeme öyküsünün immun olmamayı tahmin ettirmede bir yararı
olmadığı düşünülmüştür; bu nedenle hastalığı geçirmeme veya geçirip geçirmediğini bilmeme öyküsü olan sağlık
personelinin serolojik test sonuçlarına göre aşılanmaları gerektiği sonucuna varılmıştır. Kabakulak için aşılama kararı,
sağlık personelinin hastalığı geçirme öyküsü ve serolojik test sonucu beraber değerlendirilerek verilmelidir.
Anahtar sözcükler: Kızamık, kızamıkçık, kabakulak, suçiçeği, seroprevalans, sağlık çalışanı

Introduction

Materials and methods

Measles, rubella, mumps, and varicella virus
(MRMV) infections are typical childhood infections,
and are preventable by vaccination (1). The Centers
for Disease Control and Prevention guidelines report
that birth before 1957 is generally considered
acceptable evidence of immunity against measles,
rubella (except women who could become pregnant)
and mumps (2). When acquired during childhood,
these are clinically mild infections. However, they can
occur in susceptible adults, often causing serious
morbidity and a loss of time at work (3). Measles can
be severe among immunocompromised persons (4).
During pregnancy, varicella can cause significant
maternal, perinatal, and infant morbidity (5), and
rubella can result in congenital rubella infection (1).

A self-reported questionnaire was administered to
all HCWs included in the study to record their
histories of the infection, and vaccination against
MRMV viruses. Responses were recorded as “yes”,
“no”, and “don’t know”. A commercialized enzyme
immunoassay (ELISA) method (Radim SpA, Italy)
was used to determine the presence of anti-measles,
anti-rubella, anti-mumps, and anti-varicella
antibodies in serum samples. The assay was
performed according to the manufacturer’s
instructions. Anti-rubella IgG antibodies were
measured by quantitative assay; titers < 15 IU/mL
were considered non-reactive, 15-30 IU/mL
equivocal, and > 30 IU/mL reactive. Anti-measles,
anti-mumps, and anti-varicella IgG antibodies were
measured by qualitative assay; titers 0-0.9 were
considered non-reactive, 0.9-1.1 equivocal, and > 1.1
reactive for each one of them. All equivocal titers were
retested. If the retesting result was equivocal again, it
was considered non-reactive. The histories of the
diseases were compared to the serological testing
results to determine the positive and negative
predictive values for immunity.

In Turkey, vaccination against measles is routine,
but rubella and mumps vaccines have been included
in the routine immunization program since 2006 as a
measles-mumps-rubella vaccine. The goal of the
immunization program of our Health Ministry is to
achieve and to maintain an immunization rate of at
least 95% in the whole country (6). Vaccination
against varicella is not currently a routine application
in our country. Because of their contact with patients
or infective material from patients, health-care
workers (HCWs) are at occupational risk for these
vaccine-preventable infections (7,8). The nosocomial
transmission of these infections has been documented
in many studies (9-12). Maintenance of immunity is,
therefore, an essential part of prevention and infection
control programs for HCWs. Active immunization is
strongly recommended against MRMV viruses
because of the special risks for HCWs (8). The aim of
this study was to determine the immunity of HCWs
against MRMV infections, and to evaluate whether
self-reported history of the disease or vaccination is
predictive of immunity against these infections.
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Data were analyzed using SPSS version 13.0.
Statistical analyses were performed by chi-square test.
The history of disease was evaluated as a diagnostic
test and sensitivity, specificity, and positive and
negative predictive values were calculated for each
infection. The following definitions were used:
Positive predictive value (PPV) = Probability of
immunity among HCWs with a positive history
Negative predictive value (NPV) = Probability of
susceptibility
among
HCWs
with
a
negative/unknown history
Sensitivity = Probability of a positive history
among immune HCWs
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Specificity = Probability of a negative/unknown
history among susceptible HCWs

whether they were vaccinated or not. Thus, histories
of vaccination were not taken into consideration to
evaluate the immunity.

Results

Of the study population, 97.5% were serologically
immune to measles, 100% to rubella, 72.8% to
mumps, and 96.3% to varicella. The seroprevalence of
antibodies against mumps (72.8%) was lower than the
others, but there were no differences statistically (P >
0.05).

A total of 81 HCWs were included in the study.
Forty-four of them were male (54%) and 37 female
(46%). Their ages ranged from 20 to 57 years; the
mean age was 34.44 ± 8.07 years. Twenty-six HCWs
(32.1%) were working in surgical clinics, 28 (34.6%) in
medical clinics, 16 (19.8%) in intensive care units, and
11 (13.5%) in other departments. None of the
participants were vaccinated against rubella, mumps,
or varicella. Eighty-eight percent of them recorded
that they were vaccinated against measles within the
childhood immunization program, and 12% recorded
that they were not vaccinated or did not know

Positive predictive values of a positive history for
measles and rubella were 100% for each, whereas they
were 96.5%, and 77.4% for varicella and mumps,
respectively. The negative predictive values of a
negative or unknown history of the disease were 3.9%,
0%, 3.8%, and 30.0% for measles, rubella, varicella,
and mumps, respectively (Table).

Table. Comparison of the histories of the diseases with antibody testing results.
Antibody testing
History of disease
Positive

Negative

Total

Positive

30

0

30

Negative/unknown

49

2

51

Total

79

2

81

NPV (2/51): 3.9%

Positive

18

0

18

Sensitivity (18/81): 22.2%

Negative/unknown

63

0

63

Total

81

0

81

NPV (0/63): 0%

Positive

24

7

31

Sensitivity (24/59): 40.6%

Negative/unknown

35

15

50

Total

59

22

81

NPV (15/50): 30.0%

Positive

28

1

29

Sensitivity (28/78): 35.8%

Negative/unknown

50

2

52

Total

78

3

81

Sensitivity (30/79): 37.9%
Specificity (2/2): 100%

Measles history

PPV (30/30): 100%

Specificity (0/0): 100%
Rubella history

PPV (18/18): 100%

Specificity (15/22): 68.1%
Mumps history

Varicella history

PPV (24/31): 77.4%

Specificity (2/3): 66.6%
PPV (28/29): 96.5%
NPV (2/52): 3.8%

PPV: Positive Predictive Value, NPV: Negative Predictive Value
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Discussion
Immunity against measles was found to be 97.5%
in our study. This value was higher than the 83.1%
and 86% found in some studies (7,13), and was similar
to the 98.6% and 98.5% found in other studies (14,15).
Murray et al. reported in their study that historical
information had no benefit in predicting immunity
against measles (13). However, Trevisan et al. reported
that a self-reported history of disease had a good PPV
(94.7%) for a positive test for anti-measles antibodies
(7). Our results show that self-reported history of
measles was highly predictive of positive testing for
anti-measles antibodies (PPV: 100%); all HCWs with
a positive history were serologically immune to
measles. The negative or unknown history of the
disease was not predictive of susceptibility; of the 49
HCWs with a negative or unknown history, only 2
were found to be negative for anti-measles antibodies
(NPV: 3.9%).
All of the HCWs tested (100%) were found to be
immune to rubella. Some of the studies reported
similar high prevalence rates (98.3%, 95.5%) (7, 14),
but some of them reported low prevalence rates
against rubella compared to our results (90.4%,
88.3%) (13,15). Trevisan and Celikbas reported in
their studies that high PPVs such as 98.2% and 92%,
respectively, were found in a positive history of the
disease (7,14). In our study, all HCWs with a positive
history of rubella infection were found positive for
anti-rubella antibodies (PPV: 100%), and none of the
HCWs with a negative or unknown history were
found serologically negative, all of them were positive
(NPV: 0%). Therefore, a positive history of the disease
was found to be highly predictive of immunity, but a
negative or unknown history was not found to be
predictive of susceptibility for rubella.
The seroprevalence of antibodies against mumps
was 72.8% in our study. In different studies,
seroprevalence rates of anti-mumps antibodies were
reported as 79.9%, 85.8%, and 92.2%, respectively
(7,14,15). Trevisan and Celikbas reported in their
studies that a PPV of a positive history for mumps was
92% (7,14). In our study, PPV was found to be low
when compared to these values (77.4%); of the 31
HCWs who reported a positive history of mumps, 24
were found positive and 7 were found to be negative
for anti-mumps antibodies. The NPV of a negative or
940

unknown history of mumps was 30%; of the 50
HCWs who reported a negative or unknown history,
only 15 were serologically negative. We concluded
that positive and negative histories of the disease were
not predictive of immunity against mumps.
Among tested HCWs, 96.3% had immunity to
varicella. High seroprevalence rates were reported
similar to our results in some studies (98%, 98%,
97.2%) (3,14,15) and low prevalence rates were
reported in some other studies compared with our
rates (84%, 84%, 81.4%) (13,16,17). In our study, a
positive history of the disease was reliable for
predicting the immunity against varicella. Only one
HCW with a positive history was serologically nonreactive, and the PPV was found to be 96.5%. Similar
to our result, Holmes, Celikbas and Trevisan reported
in their studies that a self-reported history of varicella
infection was a highly accurate indicator of immunity
to the pathogen, including a positive predictive value
of 100%, 100%, and 98.3%, respectively (3,7,14). A
negative or unknown history of the disease was not
reliable (NPV: 3.8%) in our study; of the 52 HCWs
with a negative or unknown history, only 2 HCWs
were serologically non-reactive, the remaining 50
were reactive for anti-varicella antibodies. DiezDomingo et al. reported that a negative history was
poorly predictive of susceptibility, similar to our result
(16). On the other hand, Almuneef et al. reported that
a positive or negative history of varicella was an
unreliable indicator of susceptibility for varicella (17).
In the other studies, Oliveira et al. found that
historical information was ineffective in predicting
immune status to measles, rubella, mumps, and
varicella infections (18). However, Ferson et al.
suggested combining historical and serological
screening to determine the immunity in their study
(19).
In conclusion, for measles, rubella, and varicella,
high positive predictive values were detected in
HCWs with a positive history. We concluded that a
positive history of the disease is reliable for predicting
the immunity against these infections, and that
vaccination is not required for these HCWs with a
positive history. In contrast, a negative or unknown
history had no benefit in predicting susceptibility;
thus, we concluded that HCWs with a negative or
unknown history for these infections must be
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vaccinated according to the serological testing results.
For mumps, the decision for vaccination of HCWs
can be made after the evaluation of both self-reported

history, and serological testing results. We
recommend all seronegative HCWs be vaccinated
against these infections.
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